SSTR2 and meningioma: Concerning the histological subtypes, 68.2% of meningothelial meningiomas expressed somatostatin receptor SSTR-2/SSTR-2a subtype (95% CI: 43.8; 92.6) compared to 59.2% of transitional meningiomas (95% CI: 1.3; 100), 58.3% of fibroblastic meningiomas (95% CI: 50.1; 66.5), and 82.7% of atypical meningiomas (95% CI: 63.8; 100).